These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 7833161

  • 1. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma.
    Suto Y, Kodama F, Kamba M, Ohta Y.
    Acta Radiol; 1995 Jan; 36(1):102-5. PubMed ID: 7833161
    [Abstract] [Full Text] [Related]

  • 2. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
    Suto Y, Kato T, Matsuo T, Kamba M, Shimatani Y, Ohuchi Y, Nakamura K, Ohta Y.
    Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
    [Abstract] [Full Text] [Related]

  • 3. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
    Kamba M, Suto Y, Kato T.
    Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
    [Abstract] [Full Text] [Related]

  • 4. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
    Hussain MZ, Ohtomo K, Kachi K, Uchiyama G, Itai Y.
    Radiat Med; 1994 Nov; 12(1):1-5. PubMed ID: 8016397
    [Abstract] [Full Text] [Related]

  • 5. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
    Suto Y, Shimatani Y, Kato T, Kamba M, Ohuchi Y, Kodama F, Kato T, Ohta Y.
    Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
    [Abstract] [Full Text] [Related]

  • 6. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
    Chen RC, Lii JM, Chou CT, Chang TA, Chen WT, Li CS, Tu HY.
    J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
    [Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma exhibiting a concentric structure of different histologic grades: evaluation by chondroitin sulfate iron colloid-enhanced MR imaging.
    Kamba M, Suto Y, Kodama F, Ohta Y, Kobayashi J, Horie Y, Kawasaki H.
    J Magn Reson Imaging; 1996 Oct; 6(2):406-8. PubMed ID: 8859586
    [Abstract] [Full Text] [Related]

  • 8. Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings.
    Karahan OI, Yikilmaz A, Artis T, Canoz O, Coskun A, Torun E.
    Eur J Radiol; 2006 Mar; 57(3):445-52. PubMed ID: 16337762
    [Abstract] [Full Text] [Related]

  • 9. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [Abstract] [Full Text] [Related]

  • 10. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver.
    Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M.
    Hepatology; 1996 Oct; 24(4):807-12. PubMed ID: 8855180
    [Abstract] [Full Text] [Related]

  • 11. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T, Terayama N, Sanada J.
    J Comput Assist Tomogr; 2007 Oct; 31(4):557-63. PubMed ID: 17882031
    [Abstract] [Full Text] [Related]

  • 12. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K.
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [Abstract] [Full Text] [Related]

  • 13. Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.
    Imai K, Beppu T, Nakayama Y, Ishiko T, Horino K, Komori H, Masuda T, Hayashi H, Okabe H, Baba Y, Watanabe M, Takamori H, Awai K, Yamashita Y, Baba H.
    J Surg Oncol; 2009 Aug 01; 100(2):121-6. PubMed ID: 19402077
    [Abstract] [Full Text] [Related]

  • 14. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
    Suto Y, Ametani M, Kamba M, Sugihara S.
    Br J Radiol; 1996 Mar 01; 69(819):201-5. PubMed ID: 8800862
    [Abstract] [Full Text] [Related]

  • 15. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number.
    Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI.
    Radiology; 2001 Sep 01; 220(3):669-76. PubMed ID: 11526265
    [Abstract] [Full Text] [Related]

  • 16. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep 01; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 17. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec 01; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis of small hepatocellular carcinoma--imaging diagnosis and significance of tumor biopsy.
    Horigome H, Nomura T, Saso K, Joh T, Ohara H, Akita S, Sobue S, Mizuno Y, Kato Y, Kanematsu T, Murasaki G, Itoh M.
    Hepatogastroenterology; 2000 Dec 01; 47(36):1659-62. PubMed ID: 11149027
    [Abstract] [Full Text] [Related]

  • 19. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X, Xu YK, Huang QL, Wu YK.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec 01; 22(12):1061-5. PubMed ID: 12480574
    [Abstract] [Full Text] [Related]

  • 20. MR imaging of hepatocellular carcinoma.
    Onaya H, Itai Y.
    Magn Reson Imaging Clin N Am; 2000 Nov 01; 8(4):757-68. PubMed ID: 11149678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.